![]() |
市场调查报告书
商品编码
1363912
全球手术缝线市场 2023-2030Global Surgical Sutures Market 2023-2030 |
预计全球手术缝线市场在预测期内(2023-2030)将以 5.8% 的复合年增长率成长。医生使用缝合线来治疗伤口和撕裂伤。市场的成长归因于对缝合锚钉系统和 citregenTM 等技术进步的需求不断增长。在整形外科和软组织手术期间采用缝合锚固系统,特别是当软组织和骨骼之间需要安全可靠的组合时。使用传统技术将软组织连接到骨骼时,可能会出现缝线拉穿或失败等併发症。因此,市场参与者正在推出新产品来满足缝合锚钉系统的需求。例如,2022 年 12 月,Stryker 推出了 Citrefix (TM),这是一种用于足部和踝关节外科手术的缝合锚系统。这项新技术涉及使用CitregenTM,这是一种广受好评的生物可吸收物质,旨在模仿天然骨骼的成分和结构。 Citrefix 是一种可吸收、仿生缝合锚钉系统,适用于一次性缝线。
全球手术缝合线市场按产品类型、应用和最终用户细分。根据产品类型,市场分为可吸收缝线(天然缝线、合成缝线)和不可吸收缝线(尼龙、普理林等)。根据应用,市场细分为眼科手术、心血管手术、骨科手术、神经外科等。此外,根据最终用户,市场细分为医院和诊所、门诊手术中心、诊所和医生办公室。在这些应用中,由于影响老年人口的骨科疾病的数量以及全球寻求骨科手术的人数不断增加,预计骨科手术细分市场将占据相当大的市场份额。例如,根据美国国立卫生研究院的数据,全球关节炎的发生率为每 10,000 人中 203 人。
在产品类型中,可吸收细分市场预计将在全球手术缝线市场中占据重要份额。该细分市场的成长归因于对减少拆线需求的不断增长的需求。可吸收缝线,也称为可溶解缝线。可吸收缝线具有多种优点,其中之一是伤口癒合后无需将其拆除,从而节省时间并最大限度地减少患者痛苦。这种品质使它们特别适合深层组织闭合和内部手术。它们源自于易于溶解在体内的物质,例如动物肠道内的纤维或合成聚合物。可吸收缝线不依赖专业移除,例如丝线或尼龙缝线。因此,它们可有效治癒手术切口和内部伤口。
全球手术缝线市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于对创新手术技术和设备(例如带有抗菌涂层的生物相容性手术缝线)的需求增加,预计北美将在全球市场中占据显着份额。
在所有地区中,亚太地区预计在预测期内将以相当大的复合年增长率成长。预计由于老年人口中该疾病发病率的增加,对手术缝合线的需求不断增加,从而推动了该地区的成长。冠状动脉绕道手术、主动脉瓣或二尖瓣置换或修復、动脉瘤修復是常见的心血管手术。手术的一个重要组成部分是缝合。不銹钢、聚丙烯和聚酯缝合线是用于心臟缝合线的材料。根据印度联邦家庭和健康福利部于 2020 年 1 月发布的印度首次纵向老化研究 (LASI),印度每三个老年人中就有一人患有慢性病。印度近 70% 的老年人患有慢性病。研究表明,约 23% 的老年人(60 岁及以上)患有多种疾病;老年女性更有可能患有此类疾病。该调查的结果包括来自 42,000 多个家庭的信息,代表除锡金以外的所有邦和中央直辖区的 72,000 多名老年人。
根据印度首次纵向老化研究 (LASI),45 岁以上的人自我报告的严重慢性健康疾病和多种疾病的数量随着年龄的增长而增加。心血管疾病 (CVD) 和高血压是 75 岁及以上最常见的慢性健康疾病。随着个体年龄的增长,未患病的比例不断下降。据估计,45 岁以下的人中有 73% 没有患病,而 75 岁及以上的人中这一比例下降至 44%。然而,从60岁开始,下降速度却较慢。
Title: Global Surgical Sutures Market Size, Share & Trends Analysis Report by Product Type (Absorbable Sutures, and Non-absorbable Sutures), by Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurology Surgery, and Others), and by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Clinics and Physician Offices)Forecast Period (2023-2030).
The global surgical sutures market is anticipated to grow at a CAGR of 5.8% during the forecast period (2023-2030). Doctors use sutures to treat wounds and lacerations. The market's growth is attributed to growing demand for technological advancements such as suture anchor system, and citregenTM. Suture anchor systems are employed during orthopedic and soft tissue procedures, especially when a secure and reliable bond amongst the soft tissue and the bone is required. Complications such as suture pull-through or failure can occur when attaching soft tissues to bone using the conventional technique. Accordingly market players are coming up with new products to cater the demand for suture anchor system. For instance, in December 2022, Stryker launched a Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new technology involves the utilization of CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for disposable sutures.
The global surgical sutures market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into absorbable sutures (natural sutures, synthetic sutures), and non-absorbable sutures (nylon, prolene, and others). Based on the application, the market is sub-segmented into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurology surgery, and others. Further, on the basis of end-user, the market is sub-segmented into hospitals and clinics, ambulatory surgical centers, and clinics and physician offices. Among the application, the orthopedic surgery sub-segment is anticipated to hold a considerable share of the market owing to the numbers of orthopedic conditions influencing the senior citizen population and growing numbers of individuals seeking orthopedic surgery globally. For instance, according to National Institute of Health, globally, the incidence of arthritis was 203 per 10,000 individuals.
Among the product type, the absorbable sub-segment is expected to hold a significant share of the global surgical sutures market. The segmental growth is attributed to growing demand for reduced need for suture removal. Absorbable sutures, additionally known as dissolvable sutures. Absorbable sutures offer a variety of benefits such as, one of that is the fact that they don't need to be removed once the wound has healed, saving time and minimizing patient suffering. This quality makes them especially well-suited for deep tissue closures and interior procedures. They originate from substances that easily dissolve in the body, such as fibers that line the intestines of animals or synthetic polymers. Absorbable sutures are not dependent on professional removals such as silk or nylon sutures. They are therefore effective for healing surgical incisions and interior wounds.
The global surgical sutures market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increase in demand for innovative surgical techniques and equipment, such as biocompatible surgical sutures with antimicrobial coatings.
Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. The increasing demand for surgical sutures, that is subsequently fueling the region's growth, is projected to result from the disease's increased incidence among the older population. Coronary bypass surgery, aortic or mitral valve replacement or repair, and aneurysm repair are common cardiovascular procedures. A significant component of surgery is suturing. Stainless steel, polypropylene, and polyester sutures are among the materials utilized for cardiac sutures. According to the First Longitudinal Ageing Study in India (LASI), that was published by the Union Ministry of Family and Health Welfare in January 2020, both out of every three elderly individuals in India have a chronic illness. Almost 70% senior citizens in India have a chronic illness. According to the research, multi-morbidity conditions affect about 23% of senior citizens (60 years and older); older women are more likely to have such disorders. The survey's findings included information from more than 42,000 homes, representing more than 72,000 senior citizens in all states and union territories with the exception of Sikkim.
According to the First Longitudinal Ageing Study in India (LASI), the number of significant chronic health disorders and multi-morbidities that people over the age of 45 self-reported having increased with age. Cardiovascular diseases (CVD) and hypertension predominate among the chronic health disorders that are prominent among individuals 75 years of age and older. As individuals aged, the proportion of those without morbidity continually fell. It is estimated that 73% of people under the age of 45 are free of morbid conditions, and this percentage drops to 44% among individuals 75 and older. From the age of 60 onward, the decline is, nevertheless, slower.
The major companies serving the surgical sutures market include B.Braun SE, Coloplast Corp., DemeTECH Corp., Dolphin Sutures, Kono Seisakusho Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in April 2021, Dolphin Sutures, launched a non-absorbable polytetrafluoroethylene (PTFE) suture. PTFE is very strong, knots well, and is biologically inert.